Global Outsourcing in Drug Discovery 麻豆原创 Research Report 2024

Publication ID:

PB505250079

Publication Date:

May 7, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Drug discovery outsourcing refers to the outsourcing of drug discovery processes to contract manufacturers to reduce the time taken for development of a drug or to scale-up production, enjoy premium pricing, increase market share, reduce costs and serve the local markets.
The global Outsourcing in Drug Discovery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Outsourcing in Drug Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Outsourcing in Drug Discovery.
Report Scope
The Outsourcing in Drug Discovery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Outsourcing in Drug Discovery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Outsourcing in Drug Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Charles River Laboratories
ICON
Parexel
PPD
PRA Health Sciences
Wuxi AppTec
Recipharm
Segment by Type
Small Molecules
Large Molecules
Segment by Application
Hospitals and Clinics
Medical Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Outsourcing in Drug Discovery companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Outsourcing in Drug Discovery 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small Molecules
1.2.3 Large Molecules
1.3 麻豆原创 by Application
1.3.1 Global Outsourcing in Drug Discovery 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Medical Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Outsourcing in Drug Discovery 麻豆原创 Perspective (2019-2030)
2.2 Outsourcing in Drug Discovery Growth Trends by Region
2.2.1 Global Outsourcing in Drug Discovery 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Outsourcing in Drug Discovery Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Outsourcing in Drug Discovery Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Outsourcing in Drug Discovery 麻豆原创 Dynamics
2.3.1 Outsourcing in Drug Discovery Industry Trends
2.3.2 Outsourcing in Drug Discovery 麻豆原创 Drivers
2.3.3 Outsourcing in Drug Discovery 麻豆原创 Challenges
2.3.4 Outsourcing in Drug Discovery 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Outsourcing in Drug Discovery Players by Revenue
3.1.1 Global Top Outsourcing in Drug Discovery Players by Revenue (2019-2024)
3.1.2 Global Outsourcing in Drug Discovery Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Outsourcing in Drug Discovery 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Outsourcing in Drug Discovery Revenue
3.4 Global Outsourcing in Drug Discovery 麻豆原创 Concentration Ratio
3.4.1 Global Outsourcing in Drug Discovery 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Outsourcing in Drug Discovery Revenue in 2023
3.5 Outsourcing in Drug Discovery Key Players Head office and Area Served
3.6 Key Players Outsourcing in Drug Discovery Product Solution and Service
3.7 Date of Enter into Outsourcing in Drug Discovery 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Outsourcing in Drug Discovery Breakdown Data by Type
4.1 Global Outsourcing in Drug Discovery Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Outsourcing in Drug Discovery Forecasted 麻豆原创 Size by Type (2025-2030)
5 Outsourcing in Drug Discovery Breakdown Data by Application
5.1 Global Outsourcing in Drug Discovery Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Outsourcing in Drug Discovery Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Outsourcing in Drug Discovery 麻豆原创 Size (2019-2030)
6.2 North America Outsourcing in Drug Discovery 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Outsourcing in Drug Discovery 麻豆原创 Size by Country (2019-2024)
6.4 North America Outsourcing in Drug Discovery 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Outsourcing in Drug Discovery 麻豆原创 Size (2019-2030)
7.2 Europe Outsourcing in Drug Discovery 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Outsourcing in Drug Discovery 麻豆原创 Size by Country (2019-2024)
7.4 Europe Outsourcing in Drug Discovery 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Outsourcing in Drug Discovery 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Outsourcing in Drug Discovery 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Outsourcing in Drug Discovery 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Outsourcing in Drug Discovery 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Outsourcing in Drug Discovery 麻豆原创 Size (2019-2030)
9.2 Latin America Outsourcing in Drug Discovery 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Outsourcing in Drug Discovery 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Outsourcing in Drug Discovery 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Outsourcing in Drug Discovery 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Outsourcing in Drug Discovery 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Outsourcing in Drug Discovery 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Outsourcing in Drug Discovery 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Outsourcing in Drug Discovery Introduction
11.1.4 Charles River Laboratories Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.1.5 Charles River Laboratories Recent Development
11.2 ICON
11.2.1 ICON Company Detail
11.2.2 ICON Business Overview
11.2.3 ICON Outsourcing in Drug Discovery Introduction
11.2.4 ICON Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.2.5 ICON Recent Development
11.3 Parexel
11.3.1 Parexel Company Detail
11.3.2 Parexel Business Overview
11.3.3 Parexel Outsourcing in Drug Discovery Introduction
11.3.4 Parexel Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.3.5 Parexel Recent Development
11.4 PPD
11.4.1 PPD Company Detail
11.4.2 PPD Business Overview
11.4.3 PPD Outsourcing in Drug Discovery Introduction
11.4.4 PPD Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.4.5 PPD Recent Development
11.5 PRA Health Sciences
11.5.1 PRA Health Sciences Company Detail
11.5.2 PRA Health Sciences Business Overview
11.5.3 PRA Health Sciences Outsourcing in Drug Discovery Introduction
11.5.4 PRA Health Sciences Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.5.5 PRA Health Sciences Recent Development
11.6 Wuxi AppTec
11.6.1 Wuxi AppTec Company Detail
11.6.2 Wuxi AppTec Business Overview
11.6.3 Wuxi AppTec Outsourcing in Drug Discovery Introduction
11.6.4 Wuxi AppTec Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.6.5 Wuxi AppTec Recent Development
11.7 Recipharm
11.7.1 Recipharm Company Detail
11.7.2 Recipharm Business Overview
11.7.3 Recipharm Outsourcing in Drug Discovery Introduction
11.7.4 Recipharm Revenue in Outsourcing in Drug Discovery Business (2019-2024)
11.7.5 Recipharm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Charles River Laboratories
ICON
Parexel
PPD
PRA Health Sciences
Wuxi AppTec
Recipharm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.